SHREVEPORT, La. - Giant cell arteritis, also known as temporal arteritis, is a less common condition where people get inflammation of the arteries that go to the head and neck. Symptoms include, head ...

Exposure to environmental particulate matter ≤ 10 μm in diameter (PM 10) is associated with an increased risk for giant cell arteritis, particularly in older individuals aged ≥ 70 years and those with ...

Imaging analyses can improve diagnostic accuracy and confidence in patients with giant cell arteritis, according to data ...

Patients with giant cell arteritis started tocilizumab therapy an average of 43 days after diagnosis, partly because of delays in insurance approval. Overall, 82 patients (average age, 73 years; 60% ...

While not used to guide treatment, ESR and CRP typically normalize within two to four weeks after initiating therapy. 2,4 Minor increases in ESR can occur during the prednisone taper, but this does ...

Please provide your email address to receive an email when new articles are posted on . Upadacitinib bested placebo for achieving remission at 52 weeks in GCA, a new indication for the drug. The ...

These findings, published in JAMA Network Open, come from a large cohort study by Maxime Beydon and colleagues from Sorbonne ...

A 78-year-old man was referred for an ultrasound of his right eye to evaluate a small choroidal nevus. He also mentioned almost total loss of vision in his left eye over the past several days. His ...

A common medication already used for autoimmune diseases such as rheumatoid arthritis is effective for patients with giant cell arteritis, according to findings from a team at the Perelman School of ...

Mortality rates among patients with giant cell arteritis (GCA) in Canada's Ontario province rose by 15% from 2000 to 2018, a new study found, even as the general population saw declines in overall ...